Suchergebnisse - "d'Ettorre, Gabriella"

PubPharm (8)

1

Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Lombardi, F. | Belmonti, S. | Quiros-Roldan, E. | +9

2

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification : a multicenter observational study

enthalten in: BMC infectious diseases | 2016

von Latini, A. | Fabbiani, M. | Borghi, V. | +11

3

Impact of switching from lopinavir/ritonavir to boosted and un-boosted atazanavir on glucose metabolism : the ATAzanavir & GLUcose metabolism (ATAGLU) study

enthalten in: International journal of STD & AIDS | 2016

von d'Ettorre, G. | Ceccarelli, G. | Zaccarelli, M. | +8

4

State of the Art of Dual Therapy in 2015

enthalten in: AIDS reviews | 2015

von Nozza, S. | Svicher, V. | Saracino, A. | +7

5

Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease

enthalten in: BMC infectious diseases | 2011

von Esposito, A. | Floridia, M. | d'Ettorre, G. | +7

6

HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimens

enthalten in: Current HIV research | 2008

von Nicastri, E. | Palmisano, L. | Sarmati, L. | +11

7

Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens

enthalten in: Journal of medical virology | 2007

von Sarmati, L. | Parisi, S. | Nicastri, E. | +10

8

Switching from protease inhibitors to a single-class regimen of abacavir/lamivudine/zidovudine plus tenofovir in patients with HIV load suppression

enthalten in: AIDS (London, England) | 2005

von d'Ettorre, G. | Mastroianni, C. | Massetti, A. | +3

1
[1]